We are live on ! Find out more
IBER.WS

Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS

Delisted

IBER.WS was delisted on the 15th of February, 2023.

Back to rankings

20 hedge funds and large institutions have $3.27M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+20
Holders Change %
–
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
–
Reduced
–
Closed
–
Calls
$2.21M
Puts
–
Net Calls
+$2.21M
Net Calls Change
+$2.21M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$167K
2
LA
Linden Advisors
New York
+$137K
3
SC
Sculptor Capital
New York
+$129K
4
SCC
Spring Creek Capital
Kansas
+$121K
5
VI
Vestcor Inc
New Brunswick, Canada
+$121K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.45M +$91.1K +150,000 New
Citadel Advisors
2
Citadel Advisors
Florida
$209K +$167K +275,000 New
DMK
3
David M. Knott
$207K +$10.9K +18,000 New
LA
4
Linden Advisors
New York
$169K +$137K +224,999 New
SC
5
Sculptor Capital
New York
$160K +$129K +212,500 New
SCC
6
Spring Creek Capital
Kansas
$152K +$121K +200,000 New
VI
7
Vestcor Inc
New Brunswick, Canada
$152K +$121K +200,000 New
PAMP
8
Polar Asset Management Partners
Ontario, Canada
$133K +$106K +175,100 New
BFM
9
Boothbay Fund Management
New York
$123K +$7.71K +12,699 New
MCM
10
Moore Capital Management
New York
$114K +$91.1K +150,000 New
Nomura Holdings
11
Nomura Holdings
Japan
$96K +$86.1K +141,843 New
PMAM
12
Picton Mahoney Asset Management
Ontario, Canada
$76K +$60.7K +100,000 New
Wells Fargo
13
Wells Fargo
California
$64K +$50.9K +83,742 New
MP
14
Mangrove Partners
Connecticut
$57K +$45.8K +75,342 New
FTCM
15
Fir Tree Capital Management
New York
$31K +$25K +41,098 New
AA
16
AQR Arbitrage
Connecticut
$29K +$22.8K +37,500 New
PI
17
PEAK6 Investments
Illinois
$19K +$15.2K +25,000 New
PCM
18
Prelude Capital Management
New York
$13K +$10.8K +17,701 New
Capstone Investment Advisors
19
Capstone Investment Advisors
New York
$10K +$7.59K +12,500 New
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$10K +$7.59K +12,500 New

IBER.WS Hedge Fund Activity: Q2 2021 in Review

20 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) for Q2 2021, worth a combined $3.27M.

Buyers outnumbered sellers: 20 funds opened new IBER.WS positions and 0 closed out — a net gain of 20 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $167K.

  • 20 institutional investors held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $3.27M of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share stock for Q2 2021.
  • 20 funds opened new Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share positions in Q2 2021 and 0 closed out, a net change of +20 holders.
  • The largest Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share buyer in Q2 2021 was Citadel Advisors, an estimated $167K added.

Based on aggregated 13F filings for Q2 2021.